Navigation Links
The CCDC Launches the Cambridge Structural Database 2016 and Three Exciting New Software Suites
Date:11/23/2015

CAMBRIDGE, England and PISCATAWAY, New Jersey, November 23, 2015 /PRNewswire/ --

The Cambridge Crystallographic Data Centre (CCDC) announces the launch of the 2016 versions of the Cambridge Structural Database (CSD) and the CSD-System, now complemented by three powerful new software suites for researchers worldwide: CSD-Discovery to support the discovery of new molecules, CSD-Materials for the study of crystalline materials, and CSD-Enterprise, the complete set of the CCDC's applications incorporating CSD-Discovery and CSD-Materials.

Representing the most significant change in the way the CCDC provides the CSD and its application software, these new software suites mean that scientists across more research disciplines can gain huge value from all the crystal structure data in the CSD. In particular, CSD-Enterprise, the new solution for universities, enables all academic researchers, educators and students to use the CSD-System and as many CCDC-released software products as they want.

The Cambridge Structural Database is the world's comprehensive and up-to-date database of crystal structures, fully validated and ready to use. The 2016 release provides access to over 800,000 entries, and marks the biggest annual size increase to date. Containing important and unique structures not available anywhere else, the CSD is used by scientists worldwide and provides the complete crystal structure database for chemists working with any organic and metal-organic compounds.

The CSD-System offers the essential crystallographic and structural chemistry capabilities to deliver knowledge from the CSD: powerful 2D/3D search, extensive geometry analysis tools, inter- and intra-molecular interaction analysis, high impact graphics, and powerful new CSD Python API connectivity for the creation of custom CSD-driven analyses and workflows.

CSD-Discovery provides research organizations with all the software tools for discovering new molecules: extended CSD API components, new CSD-driven Conformer Generator and Ligand Overlay capabilities for understanding and optimizing molecular geometry, and GOLD and Relibase for ligand-receptor docking and analysis.

CSD-Materials comprises CSD-driven tools for organizations exploring new materials and formulations. By analysing intra-and intermolecular interactions within the crystal lattice, scientists can understand the underlying structure of their materials and refine their properties.

 "This release marks the biggest change in the software delivered by the CCDC to the research communities," commented Colin Groom, Executive Director of the CCDC. "Our new software suites enable users to access all the data in the CSD with all the applications they need to advance their research. I'm particularly proud that we could mark the 50th anniversary of the CSD with the launch of CSD-Enterprise, delivering to all academic CSD users a free upgrade to the complete CCDC software collection, including all the functionality of CSD-System, CSD-Discovery and CSD-Materials."

About The Cambridge Crystallographic Data Centre 

The Cambridge Crystallographic Data Centre is dedicated to the advancement of chemistry and crystallography for the public benefit. It supports structural chemistry worldwide through collaborative research studies and by developing the Cambridge Structural Database (CSD), the world's only comprehensive, up-to-date, and fully-curated knowledge base of small molecule crystal structures.

The CSD was established 50 years ago as one of the world's first numerical databases and now comprises over 800,000 entries. The CCDC enhances its value to research scientists by providing state-of-the-art structural analysis software and expert research services for understanding structural chemistry, discovering new molecules and engineering new materials. All entries in the CSD are available online and the entire database and associated software services are delivered to around 1,400 research sites worldwide, including academic institutions in 80 countries and all of the world's top pharmaceutical and chemical companies.

Originating in the Department of Chemistry at the University of Cambridge, the CCDC is now a UK Research Council Independent Research Organisation and a University of Cambridge Partner Institute, constituted as a registered charity. It has operations in Cambridge and New Jersey. With 50 years of scientific expertise, the CCDC has demonstrated its strong track record in basic research through more than 750 peer-reviewed publications. www.ccdc.cam.ac.uk

Contact: 

CCDC: Paul Davie, General Manager, Cambridge Crystallographic Data Centre Inc., davie@ccdc.cam.ac.uk



'/>"/>
SOURCE Cambridge Crystallographic Data Centre (CCDC)
Copyright©2015 PR Newswire.
All rights reserved


Related biology technology :

1. PatientCrossroads Launches First Online Narcolepsy Patient Registry
2. PotBotics Launches Public Beta Of Medical Cannabis Recommendation Engine
3. Proove Biosciences Launches Monthly Real World Evidence Webinars to Educate Physicians on Proove Genetic Testing™
4. Janssen Launches New Platform Focused On Improving Disease Monitoring For People Living With Inflammatory Bowel Diseases (IBD)
5. Pistoia Alliance Launches New Chemical Safety Library Project
6. Proove Biosciences Launches New Test Report for Proove Drug Metabolism Genetic Profile
7. SmokeCloak® EASY DNA Launches at $2399, Stops, Deters and IDs Intruders
8. Norgen Biotek Launches Novel Exosome Isolation and Exosomal microRNA Purification Kits
9. Pathway Biologic Launches Powerful New Microbial Product
10. HIMSS-Elsevier Digital Healthcare Award Program Launches for the First Time in the Middle East
11. Eurofins Pharma Discovery Services Launches New eCommerce Platform for Drug Discovery Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
Breaking Biology Technology:
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:4/4/2017)... NEW YORK , April 4, 2017   ... solutions, today announced that the United States Patent and ... The patent broadly covers the linking of an iris ... the same transaction) and represents the company,s 45 th ... our latest patent is very timely given the multi-modal ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
Breaking Biology News(10 mins):